Daniel Radin

6PUBLICATIONS
6CO-AUTHORS
Molecular targetsPharmacogenomicsProteins and peptidesPharmaceutical delivery technologiesEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 27, 2025
AMPA Receptor Modulation in the Treatment of High-Grade Glioma: Translating Good Science into Better Outcomes.

Daniel P Radin

|Feb 11, 2025
Preclinical Pharmacology of CX1837, a High-Impact Ampakine with an Improved Safety Margin: Implications for Treating Alzheimer's Disease and Ischemic Stroke.

Daniel P Radin, Sheng Zhong, Rok Cerne

|Sep 20, 2024
High Impact AMPAkines Induce a Gq-Protein Coupled Endoplasmic Calcium Release in Cortical Neurons: A Possible Mechanism for Explaining the Toxicity of High Impact AMPAkines.

Daniel P Radin, Sheng Zhong, Rok Cerne

|Sep 20, 2024
Preclinical characterization of a water-soluble low-impact ampakine prodrug, CX1942 and its active moiety, CX1763.

Daniel P Radin, Sheng Zhong, Rok Cerne

|Jan 31, 2024
Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo.

Daniel P Radin, Sophie Shifman, Ian R Outhwaite

|Mar 11, 2021
A distinct microglial subset at the tumor-stroma interface of glioma.

Michael D Caponegro, Ki Oh, Miguel M Madeira

Pageof 1

Frequent Collaborators

2 joint publications

Stella E Tsirka

1 joint publications

Sophie Shifman

1 joint publications

Ian R Outhwaite

1 joint publications

Aryan Sharma